Patent: 8,598,194
✉ Email this page to a colleague
Summary for Patent: 8,598,194
Title: | Polycyclic agents for the treatment of respiratory syncytial virus infections |
Abstract: | The present invention relates to polycyclic antiviral compounds, and salts thereof, methods for their preparation and compositions containing them, and the use of the compounds and composition in the treatment of viral infections. |
Inventor(s): | Mitchell; Jeffrey Peter (Seaholme, AU), Draffan; Alistair George (St. Kilda East, AU), Sanford; Vanessa Anne (Ryde, AU), Bond; Silas (Lynbrook, AU), Lim; Chin Yu (Glen Waverley, AU), Mayes; Penelope Anne (Eltham North, AU) |
Assignee: | Biota Scientific Management Pty Ltd. (Notting Hill, Victoria, AU) |
Application Number: | 12/443,177 |
Patent Claims: | see list of patent claims |
Details for Patent 8,598,194
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Swedish Orphan Biovitrum Ab (publ) | SYNAGIS | palivizumab | For Injection | 103770 | 06/19/1998 | ⤷ Try a Trial | 2039-02-26 |
Swedish Orphan Biovitrum Ab (publ) | SYNAGIS | palivizumab | Injection | 103770 | 07/23/2004 | ⤷ Try a Trial | 2039-02-26 |
Hoffmann-la Roche Inc. | PEGASYS COPEGUS COMBINATION PACK | peginterferon alfa-2a and ribavirin | 125083 | 06/04/2004 | ⤷ Try a Trial | 2039-02-26 | |
Schering Corporation A Subsidiary Of Merck & Co., Inc. | PEGINTRON/ REBETOL COMBO PACK | peginterferon alfa-2b and ribavirin | 125196 | 06/13/2008 | ⤷ Try a Trial | 2039-02-26 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |